Objective To develop and validate a novel risk prediction model for incident major adverse liver outcomes (MALO) in a primary care setting. Design Population based cohort study. Setting Sweden, with ...
Survivors of high-risk neuroblastoma treated with modern therapies demonstrated a substantial burden of late effects, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback